Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-075482·AP11 Ltd
Schedule 13G ownership disclosure
Sagimet Biosciences Inc
Series A common stock · CUSIP: 786700104
Event date: 2023-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AP11 Limited
Shares: 1,654,701 · Class: 5.4%
- Ascletis Pharma Inc.
Shares: 1,654,701 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-075482
- Form type
- SCHEDULE 13G
- Filer
- AP11 Ltd
- CIK
- CIK 2069316
- Filed
- May 20, 2025
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership